Cargando…
Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease
It is well established that lysosomal glucocerebrosidase gene (GBA) variants are a risk factor for Parkinson’s disease (PD), with increasing evidence suggesting a loss of function mechanism. One question raised by this genetic association is whether variants of genes involved in other aspects of sph...
Autores principales: | Wallom, Kerri-Lee, Fernández-Suárez, María E., Priestman, David A., te Vruchte, Danielle, Huebecker, Mylene, Hallett, Penelope J., Isacson, Ole, Platt, Frances M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979855/ https://www.ncbi.nlm.nih.gov/pubmed/34757540 http://dx.doi.org/10.1007/s10719-021-10023-x |
Ejemplares similares
-
Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels
por: te Vruchte, Danielle, et al.
Publicado: (2022) -
Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain
por: Hallett, Penelope J., et al.
Publicado: (2018) -
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
por: Huebecker, Mylene, et al.
Publicado: (2019) -
Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
por: Huebecker, Mylene, et al.
Publicado: (2020) -
Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
por: Brekk, Oeystein R., et al.
Publicado: (2020)